Residual macrovascular risk in 2013: what have we learned? (2014)
- Authors:
- Fruchart, Jean-Charles
- Davignon, Jean
- Hermans, Michel P.
- Al-Rubeaan, Khalid
- Amarenco, Pierre
- Assmann, Gerd
- Barter, Philip
- Betteridge, John
- Bruckert, Eric
- Cuevas, Ada
- Farnier, Michel
- Ferrannini, Ele
- Fioretto, Paola
- Genest, Jacques
- Ginsberg, Henry N.
- Gotto, Antonio M.
- Hu, Dayi
- Kadowaki, Takashi
- Kodama, Tatsuhiko
- Krempf, Michel
- Matsuzawa, Yuji
- Núñez-Cortés, Jesús
- Monfil, Carlos
- Ogawa, Hisao
- Plutzky, Jorge
- Rader, Daniel J.
- Sadikot, Shaukat
- Santos, Raul D.
- Shlyakhto, Evgeny
- Sritara, Piyamitr
- Sy, Rody
- Tall, Alan
- Tan, Chee Eng
- Tokgözoğlu, Lale
- Toth, Peter P.
- Valensi, Paul
- Wanner, Christoph
- Zambon, Alberto
- Zhu, Junren
- Zimmet, Paul
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1186/1475-2840-13-26
- Subjects: FATORES DE RISCO; SISTEMA CARDIOVASCULAR (ANORMALIDADES); DISLIPIDEMIAS; DIABETES MELLITUS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Cardiovascular Diabetology
- ISSN: 1475-2840
- Volume/Número/Paginação/Ano: v. 13, n. 26, 17 p. (on-line), 2014
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
FRUCHART, Jean-Charles; DAVIGNON, Jean; HERMANS, Michel P.; et al. Residual macrovascular risk in 2013: what have we learned? Cardiovascular Diabetology, London, v. 13, n. 26, p. 17 (on-line), 2014. Disponível em: < http://www.cardiab.com/content/pdf/1475-2840-13-26.pdf > DOI: 10.1186/1475-2840-13-26. -
APA
Fruchart, J. -C., Davignon, J., Hermans, M. P., Al-Rubeaan, K., Amarenco, P., Assmann, G., et al. (2014). Residual macrovascular risk in 2013: what have we learned? Cardiovascular Diabetology, 13( 26), 17 (on-line). doi:10.1186/1475-2840-13-26 -
NLM
Fruchart J-C, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, Barter P, Betteridge J, Bruckert E, Cuevas A, Farnier M, Ferrannini E, Fioretto P, Genest J, Ginsberg HN, Gotto AM, Hu D, Kadowaki T, Kodama T, Krempf M, Matsuzawa Y, Núñez-Cortés J, Monfil C, Ogawa H, Plutzky J, Rader DJ, Sadikot S, Santos RD, Shlyakhto E, Sritara P, Sy R, Tall A, Tan CE, Tokgözoğlu L, Toth PP, Valensi P, Wanner C, Zambon A, Zhu J, Zimmet P. Residual macrovascular risk in 2013: what have we learned? [Internet]. Cardiovascular Diabetology. 2014 ; 13( 26): 17 (on-line).Available from: http://www.cardiab.com/content/pdf/1475-2840-13-26.pdf -
Vancouver
Fruchart J-C, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, Barter P, Betteridge J, Bruckert E, Cuevas A, Farnier M, Ferrannini E, Fioretto P, Genest J, Ginsberg HN, Gotto AM, Hu D, Kadowaki T, Kodama T, Krempf M, Matsuzawa Y, Núñez-Cortés J, Monfil C, Ogawa H, Plutzky J, Rader DJ, Sadikot S, Santos RD, Shlyakhto E, Sritara P, Sy R, Tall A, Tan CE, Tokgözoğlu L, Toth PP, Valensi P, Wanner C, Zambon A, Zhu J, Zimmet P. Residual macrovascular risk in 2013: what have we learned? [Internet]. Cardiovascular Diabetology. 2014 ; 13( 26): 17 (on-line).Available from: http://www.cardiab.com/content/pdf/1475-2840-13-26.pdf - Efeitos da sinvastatina no perfil lipidico e na remocao plasmatica de uma emulsao lipidica semelhante a lipoproteina de baixa densidade (ldl) em pacientes hipercolesterolemicos
- C-reactive protein is independently associated with coronary atherosclerosis burden among octogenarians
- HDL cholesterol level and mortality occurrence in the elderly [Editorial]: is the good cholesterol always good?
- ClinVar database of global familial hypercholesterolemia-associated DNA variants
- Cholesterol and inflammation [Editorial]: The lesser the better in atherothrombosis
- Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults
- Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia
- Treatment effect of alirocumab according to age group, smoking status, and hypertension: pooled analysis from 10 randomized ODYSSEY studies
- PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia
- HDL functionality modulates carotid artery intima-media thickness in individuals with marked hyperalphalipoproteinemia
Informações sobre o DOI: 10.1186/1475-2840-13-26 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
